Heart News and Research

RSS

PolyMedix Phase 1B/2 clinical study data presented at ATVB meeting

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that clinical data with PMX-60056 were presented at the American Heart Association's Arteriosclerosis, Thrombosis, and Vascular Biology Meeting in Chicago on April 28, 2011.

4 May 2011

Thoratec reports $99.5 million revenue for first quarter 2011

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that revenues from continuing operations in the first quarter of fiscal 2011 were $99.5 million versus revenues of $99.3 million in the same period a year ago.

4 May 2011

Nile Therapeutics initiates cenderitide Phase I trial in heart failure

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced dosing of the first patient in a Phase I clinical trial investigating the use of subcutaneous cenderitide.

3 May 2011

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

3 May 2011

Vidyo, American Well partner to enable Online Care services

Vidyo, Inc., the first company to deliver personal telepresence, today announced a partnership with American Well, whose Online Care Suite connects providers and patients for live, immediate, and clinically meaningful encounters using the Web or phone.

3 May 2011

Study finds disparities in male, female patients for heart disease treatment at U.S. hospitals

A study released today by HealthGrades, the nation's leading, independent source of physician information and hospital quality ratings, found notable disparities in the treatment and outcomes of male and female patients at U.S. hospitals.

3 May 2011

AHA recommends Omega-3 EPA/DHA intake for individuals with elevated triglyceride levels

The American Heart Association recently issued its first ever statement on triglyceride management that includes recommendations for Omega-3 EPA/DHA intake.

3 May 2011

Belly fat predicts heart-disease risk better than BMI: Study

According to the latest study the fat around the belly is the chief culprit in the link between obesity and cardiovascular disease. This study raises the possibility that people can be overweight without significantly raising their heart risk, so long as they carry the extra fat in places other than their belly. In fact, a few extra pounds may even lower the risk of death from heart disease, researchers found.

3 May 2011

Doctors should consider catheterization for diagnosing children with heart defects: AHA

Doctors should consider using catheterization as a treatment tool in addition to its established role in diagnosing children with heart defects, according to a new American Heart Association scientific statement.

3 May 2011

Statins can help reduce lung damage in severe abdominal sepsis

Statins may be best known for their ability to reduce cholesterol, but a research report appearing in the May 2011 issue of the Journal of Leukocyte Biology shows that these same drugs could also play a crucial role in the reduction of lung damage resulting from severe abdominal sepsis and infection.

3 May 2011

First cryoablation procedure using new mapping catheter performed at Baylor Heart and Vascular Hospital

Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.

3 May 2011

Cyberonics initiates first implant of AspireSR product in epilepsy patients

Cyberonics, Inc., a global leader in epilepsy management, today announced the first implant of its AspireSR™ seizure response product on April 27, 2011.

3 May 2011

New non-invasive device can measure brain's precise temperature

Doctors have long sought a way to directly measure the brain's temperature without inserting a probe through the skull. Now researchers have developed a way to get the brain's precise temperature with a device the diameter of a poker-chip that rests on a patient's head, according to findings presented May 1 at the annual meeting of the Pediatric Academic Societies in Denver.

3 May 2011

Oragenics announces availability of oral care probiotics for children and adults

Florida-based biopharmaceutical company Oragenics, Inc. has announced that its oral care probiotics for children and adults will be available in Australia and New Zealand through an exclusive agreement with Australian Pharmaceutical Industries, owner of the Priceline pharmacy retail chain, and one of the leading service providers to the pharmacy industry.

3 May 2011

FDA approves Achieve Mapping Catheter for use in first patient procedure

Medtronic, Inc. today announced the U.S. Food and Drug Administration approval for use, and the first patient procedure using the Achieve™ Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation.

3 May 2011

New antioxidant may prevent liver damage in chronic alcoholics

An antioxidant may prevent damage to the liver caused by excessive alcohol, according to new research from the University of Alabama at Birmingham.

3 May 2011

Poor sleep may contribute to high insulin resistance in diabetic people

In the largest study of it kind to establish a link between sleep and diabetes, researchers found that people with diabetes who sleep poorly have higher insulin resistance, and a harder time controlling the disease.

3 May 2011

Animal studies reveal new route to treating heart disease

Scientists at Johns Hopkins have shown in laboratory experiments in mice that blocking the action of a signaling protein deep inside the heart’s muscle cells blunts the most serious ill effects of high blood pressure on the heart. These include heart muscle enlargement, scar tissue formation and loss of blood vessel growth.

2 May 2011

Women with PCOS show high levels of blood markers linked with cardiovascular disease

A new study presented at the European Congress of Endocrinology shows that women with polycystic ovary syndrome show higher levels of blood markers associated with cardiovascular disease than control groups.

2 May 2011

Secondhand smoke exposure linked to high blood pressure in boys

Exposure to secondhand smoke, even at extremely low levels, is associated with increased blood pressure in boys, according to new research being presented Sunday, May 1, at the Pediatric Academic Societies annual meeting in Denver.

2 May 2011